November 7, 2023 10:29 AM EST
Pharma
Marketing

Mar­ket­ingRx roundup: Sanofi, Re­gen­eron re­new Dupix­ent asth­ma ef­fort; Bausch Health bat­tles sea­son­al af­fec­tive dis­or­der

Beth Snyder Bulik

Senior Editor

Sanofi and Re­gen­eron are switch­ing up the fo­cus in their “Lung­Zone” cam­paign for Dupix­ent, this time high­light­ing asth­ma in chil­dren. This year’s dig­i­tal and video …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times